A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index


About Amylin Pharmaceuticals:

Amylin Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing innovative medicines to improve the lives of people with metabolic diseases. The Company’s two late-stage, first-in-class diabetes product candidates are:

SYMLIN® (pramlintide acetate) and Exenatide (synthetic exendin-4)

Building on its experience in the diabetes field, the Company is developing candidates for cardiovascular disease and obesity by utilizing its research experience with the metabolic properties common to all three conditions.


Product Pipeline:


SYMLIN is a synthetic version of human amylin, a hormone secreted with insulin by the beta cells in the pancreas-- read more

Exenatide is a first-in-class drug candidate for the treatment of type 2 diabetes read more

Exentatide LAR -- a sustained release formulation of exenatide, referred to as exenatide LAR. This development program utilizes Alkermes’ patented and proprietary Medisorb® injectable sustained release drug delivery technology

AC137 is in development for the potential treatment of obesity. AC137 is pramlintide acetate, the same compound as SYMLIN, Amylin’s lead drug candidate for type 1 and insulin-using type 2 diabetes- read more.



NIH Trials using Exenatide

More on Amylin
Pharmaceuticals :

Home Page

Key Statistics fo Amylin

Basic Chart for Amylin

Analyst Opinion

Analysts Estimates

Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.